Latest Financial Performance News

SomnoMed Limited reported a robust FY25 with revenue surpassing guidance and a landmark FDA clearance for its Rest Assure® oral device, setting the stage for sustained growth in oral appliance therapy.

SDI Limited reported stable FY25 revenue with improved margins and advancing Montrose project, while regional sales showed mixed results.

SDI Limited reported a steady FY2025 with a slight profit increase, driven by growth in aesthetic and whitening products and the launch of its new amalgam replacement, Stela. The company also announced plans for a new factory to boost production capacity.

Alliance Aviation Services reported record FY25 revenue and flying hours but faces margin pressures from rising costs and a major contract renegotiation. The company’s refreshed leadership is focused on operational improvements and debt reduction in FY26.

Swoop Holdings Limited showcased robust subscriber growth and strategic divestments at its November 2025 AGM, targeting significant margin improvements and operational efficiencies.

NRW Holdings reported robust FY25 results with $3.3 billion revenue and $207.9 million underlying EBITA, boosted by strategic acquisitions including Fredon Industries. The company raised its FY26 guidance, projecting revenue near $4.1 billion and EBITA between $260 million and $265 million, underpinned by a $20.9 billion project pipeline.

Ironbark Capital reported an 8.4% portfolio return for FY25 and announced plans to rebrand and introduce quarterly dividends to address its persistent discount to net tangible assets.

Advanced Innergy Holdings Ltd (ASX, AIH) reported unaudited proforma FY25 results exceeding prospectus forecasts, driven by strong organic growth and the strategic acquisition of Ovun. The company reaffirms its FY26 guidance, supported by a robust orderbook and pipeline.

Advanced Innergy Holdings Ltd (ASX – AIH) has completed its corporate restructure and ASX listing, reporting a 10% revenue increase and a strong £27.6 million adjusted EBITDA for FY25.

New Zealand King Salmon reported an FY25 net loss driven by a shortened reporting period and biological challenges, while advancing its Blue Endeavour pilot project despite delays. The company projects a cautious recovery in FY26 with EBITDA guidance between NZD 9 million and 15 million.

New Zealand King Salmon Investments Limited has revealed a significant 44% decline in revenue alongside a net loss of NZD 6.3 million for the eight months ending September 2025, signaling challenges ahead for the seafood producer.

Tower Limited has reported a record underlying profit for FY25, driven by improved claims ratios, customer growth, and strategic initiatives including expanded risk-based pricing. The insurer declared increased dividends and outlined a positive growth outlook for FY26.